Image

A Cohort Study of Chronic Cardiovascular Diseases

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

This prospective cohort study aims to establish cohorts of patients with chronic cardiovascular disease, including refractory and secondary hypertension, coronary heart disease, atrial fibrillation, ventricular arrhythmias, structural heart disease, pulmonary hypertension, heart failure and rare diseases of the cardiovascular system, and patients with implantations of cardiac pacemaker, in order to dynamically describe the population characteristics, diagnosis and treatment status and long-term prognosis and analyze the factors affecting the choice of treatment plan, long-term management quality and clinical prognosis of these patients.

Eligibility

This study includes 9 disease-specific cohorts. The specific inclusion and exclusion

criteria are as following:

  1. Refractory and secondary hypertension

    Inclusion Criteria:

    • Patients diagnosed as refractory hypertension and/or secondary hypertension
    • Patients willing to accept long-term follow-up and regular return visits

Exclusion Criteria:

  • Severe diseases of other systems may affecting the life span of patients 2. Coronary heart disease

Inclusion Criteria:

  • Patients undergoing coronary angiography and interventional therapy in the cath lab
  • Patients undergoing coronary angiography and functional assessment in the cath lab
  • Patients diagnosed as acute myocardial infarction

Exclusion Criteria:

  • Severe diseases of other systems may affecting the life span of patients
  • Regular return visits not available 3. Atrial fibrillation

Inclusion Criteria:

  • PAtrial fibrillation diagnosed by electrocardiogram or holter (duration >30 seconds)
  • Patients willing to accept long-term follow-up and regular return visits

Exclusion Criteria:

  • Severe diseases of other systems may affecting the life span of patients
  • New-onset atrial fibrillation during the perioperative period of major surgery 4. Ventricular arrhythmias

Inclusion Criteria:

  • Patients diagnosed as ventricular tachycardia, ventricular premature beat
  • Patients willing to accept long-term follow-up and regular return visits

Exclusion Criteria:

  • Severe diseases of other systems may affecting the life span of patients
  • A transient cause of ventricular arrhythmia was determined by the doctor, and long-term follow-up was not required 5. Cardiac pacemaker implantation

Inclusion Criteria:

  • Patients with permanent pacemaker implantations due to various causes (including bradycardia pacing, implantable cardioverter defibrillator, cardiac resynchronization therapy, leadless cardiac pacemaker, etc.)
  • Patients willing to accept long-term follow-up and regular return visits

Exclusion Criteria:

  • Severe diseases of other systems may affecting the life span of patients 6. Structural heart disease

Inclusion Criteria:

  • Patients diagnosed as structural heart disease, including congenital heart disease and severe valvular disease (moderate and above valvular stenosis or incomplete closure)
  • Patients willing to accept long-term follow-up and regular return visits

Exclusion Criteria:

  • Severe diseases of other systems may affecting the life span of patients 7. Pulmonary hypertension

Inclusion Criteria:

  • Patients diagnosed as pulmonary hypertension
  • Patients willing to accept long-term follow-up and regular return visits

Exclusion Criteria:

  • Severe diseases of other systems may affecting the life span of patients 8. Heart failure

Inclusion Criteria:

  • Patients diagnosed as heart failure
  • Patients willing to accept long-term follow-up and regular return visits

Exclusion Criteria:

  • Severe diseases of other systems may affecting the life span of patients 9. Rare diseases of the cardiovascular system

Inclusion Criteria:

  • Patients diagnosed as rare diseases in the catalog published by National Health Commission of the People's Republic of China
  • Patients willing to accept long-term follow-up and regular return visits

Exclusion Criteria:

  • Severe diseases of other systems may affecting the life span of patients

Study details

Cardiovascular Diseases, Cohort Studies

NCT04996342

Peking University First Hospital

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.